Clinical Trial Update: Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 2 study evaluating a single dose of LS301-IT for fluorescence intraoperative molecular imaging in patients with no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• LS301-IT

Snippet

Sponsor: Integro Theranostics | Conditions: Non Small Cell Lung Cancer (NSCLC) | Phase 2 | Status: RECRUITING